Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 159

1.

Preventing discrimination against volunteers in prophylactic HIV vaccine trials: lessons from a phase II trial.

Sheon AR, Wagner L, McElrath MJ, Keefer MC, Zimmerman E, Israel H, Berger D, Fast P.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Dec 15;19(5):519-26.

PMID:
9859967
[PubMed - indexed for MEDLINE]
2.

Trial-related discrimination in HIV vaccine clinical trials.

Allen M, Israel H, Rybczyk K, Pugliese MA, Loughran K, Wagner L, Erb S.

AIDS Res Hum Retroviruses. 2001 May 20;17(8):667-74.

PMID:
11429107
[PubMed - indexed for MEDLINE]
3.

Negative social impacts among volunteers in an HIV vaccine efficacy trial.

Fuchs J, Durham M, McLellan-Lemal E, Vittinghoff E, Colfax G, Gurwith M, Buchbinder S.

J Acquir Immune Defic Syndr. 2007 Nov 1;46(3):362-8.

PMID:
17721399
[PubMed - indexed for MEDLINE]
4.

Behavioral and social issues among volunteers in a preventive HIV vaccine trial in Thailand.

Jenkins RA, Thapinta D, Morgan PA, Wongkamhaeng S, Sornsathapornkul P, Bussaratid V, Sontirat A, Pitisuttithum P, Thongchareoen P, Khamboonruang C, Suriyanon V, Nitayaphan S, Brown AE; Thai AIDS Vaccine Evaluation Group.

J Acquir Immune Defic Syndr. 2005 Dec 15;40(5):592-9.

PMID:
16284537
[PubMed - indexed for MEDLINE]
5.

Evaluation of behavioral and social issues among Thai HIV vaccine trial volunteers.

Thapinta D, Jenkins RA, Celentano DD, Nitayaphan S, Buapunth P, Triampon A, Morgan PA, Khamboonruang C, Suwanarach C, Yutabootr Y, Ruckphaopunt S, Suwankiti S, Tubtong V, Cheewawat W, McNeil JG, Michael RA.

J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Mar 1;20(3):308-14.

PMID:
10077182
[PubMed - indexed for MEDLINE]
6.

Willingness to participate in AIDS vaccine trials among high-risk populations in northern Thailand.

Celentano DD, Beyrer C, Natpratan C, Eiumtrakul S, Sussman L, Renzullo PO, Khamboonruang C, Nelson KE.

AIDS. 1995 Sep;9(9):1079-83.

PMID:
8527082
[PubMed - indexed for MEDLINE]
7.

Incentives and disincentives to participate in prophylactic HIV vaccine research.

Jenkins RA, Temoshok LR, Virochsiri K.

J Acquir Immune Defic Syndr Hum Retrovirol. 1995 May 1;9(1):36-42.

PMID:
7712233
[PubMed - indexed for MEDLINE]
8.

Social impact of preventive HIV vaccine clinical trial participation: a model of prevention, assessment and intervention.

Allen M, Lau CY.

Soc Sci Med. 2008 Feb;66(4):945-51. Epub 2007 Dec 26.

PMID:
18162272
[PubMed - indexed for MEDLINE]
9.

Social harms in injecting drug users participating in the first phase III HIV vaccine trial in Thailand.

Pitisuttithum P, Choopanya K, Bussaratid V, Vanichseni S, van Griensven F, Phonrat B, Martin M, Vimutsunthorn E, Sangkum U, Kitayaporn D, Tappero JW, Heyward W, Francis D.

J Med Assoc Thai. 2007 Nov;90(11):2442-8.

PMID:
18181333
[PubMed - indexed for MEDLINE]
10.

Community heroes or "high-risk" pariahs? Reasons for declining to enroll in an HIV vaccine trial.

Newman PA, Daley A, Halpenny R, Loutfy M.

Vaccine. 2008 Feb 20;26(8):1091-7. doi: 10.1016/j.vaccine.2007.12.016. Epub 2008 Jan 3.

PMID:
18237829
[PubMed - indexed for MEDLINE]
11.

Starting from scratch: program development and lessons learned from HIV vaccine trial counseling in Thailand.

Thapinta D, Jenkins RA.

Contemp Clin Trials. 2007 Jul;28(4):409-22. Epub 2006 Nov 21.

PMID:
17196444
[PubMed - indexed for MEDLINE]
12.

Motivation, recruitment, and screening of volunteers for a phase I/II HIV preventive vaccine trial in Thailand.

Jenkins RA, Chinaworapong S, Morgan PA, Ruangyuttikarn C, Sontirat A, Chiu J, Michael RA, Nitayaphan S, Khamboonruang C.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Jun 1;18(2):171-7.

PMID:
9637582
[PubMed - indexed for MEDLINE]
13.

Willingness to participate and enroll in a phase 3 preventive HIV-1 vaccine trial.

O'Connell JM, Hogg RS, Chan K, Strathdee SA, McLean N, Martindale SL, Willoughby B, Remis R.

J Acquir Immune Defic Syndr. 2002 Dec 15;31(5):521-8.

PMID:
12473841
[PubMed - indexed for MEDLINE]
14.

Enrollment of racial/ethnic minorities in NIAID-funded networks of HIV vaccine trials in the United States, 1988 to 2002.

Djomand G, Katzman J, di Tommaso D, Hudgens MG, Counts GW, Koblin BA, Sullivan PS.

Public Health Rep. 2005 Sep-Oct;120(5):543-8.

PMID:
16224987
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Willingness to volunteer in future preventive HIV vaccine trials: issues and perspectives from three U.S. communities.

Strauss RP, Sengupta S, Kegeles S, McLellan E, Metzger D, Eyre S, Khanani F, Emrick CB, MacQueen KM.

J Acquir Immune Defic Syndr. 2001 Jan 1;26(1):63-71.

PMID:
11176270
[PubMed - indexed for MEDLINE]
16.

"Once I begin to participate, people will run away from me": understanding stigma as a barrier to HIV vaccine research participation in Kenya.

Nyblade L, Singh S, Ashburn K, Brady L, Olenja J.

Vaccine. 2011 Nov 8;29(48):8924-8. doi: 10.1016/j.vaccine.2011.09.067. Epub 2011 Oct 1.

PMID:
21964057
[PubMed - indexed for MEDLINE]
17.
18.

Participation in two phase II prophylactic HIV vaccine trials in the UK.

Gray K, Legg K, Sharp A, Mackie N, Olarinde F, De Souza C, Weber J, Peters B.

Vaccine. 2008 Jun 2;26(23):2919-24. doi: 10.1016/j.vaccine.2008.03.039. Epub 2008 Apr 9.

PMID:
18450339
[PubMed - indexed for MEDLINE]
19.

Domestic AIDS vaccine trials: addressing the potential for social harm to the subjects of human experiments.

Leider PA.

Calif Law Rev. 2000;88:1185-232.

PMID:
11067733
[PubMed - indexed for MEDLINE]
20.

Unique risks to volunteers in HIV vaccine trials.

Frey SE.

J Investig Med. 2003 Feb;51 Suppl 1:S18-20.

PMID:
12664950
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk